A comprehensive methylome map of lineage commitment from hematopoietic progenitors

By Hong Ji, L. R. Ehrlich, J. Seita, Peter N. Murakami, A. Doi, P. Lindau, Hwajin Lee, Martin J. Aryee, Rafael A. Irizarry, Kitai Kim and 8 more. Nature, 2010

649 citations recorded by the source corpus.

Epigenetic modifications must underlie lineage-specific differentiation as terminally differentiated cells express tissue-specific genes, but their DNA sequence is unchanged. Haematopoiesis provides a well-defined model to study epigenetic modifications during cell-fate decisions, as multipotent progenitors (MPPs) differentiate into progressively restricted myeloid or lymphoid progenitors. Although DNA methylation is critical for myeloid versus lymphoid differentiation, as demonstrated by the myeloerythroid bias in Dnmt1 hypomorphs, a comprehensive DNA methylation map of haematopoietic progenitors, or of any multipotent/oligopotent lineage, does not exist. Here we examined 4.6 million CpG sites throughout the genome for MPPs, common lymphoid progenitors (CLPs), common myeloid progenitors (CMPs), granulocyte/macrophage progenitors (GMPs), and thymocyte progenitors (DN1, DN2, DN3). Marked epigenetic plasticity accompanied both lymphoid and myeloid restriction. Myeloid commitment involved less global DNA methylation than lymphoid commitment, supported functionally by myeloid skewing of progenitors following treatment with a DNA methyltransferase inhibitor. Differential DNA methylation correlated with gene expression more strongly at CpG island shores than CpG islands. Many examples of genes and pathways not previously known to be involved in choice between lymphoid/myeloid differentiation have been identified, such as Arl4c and Jdp2. Several transcription factors, including Meis1, were methylated and silenced during differentiation, indicating a role in maintaining an undifferentiated state. Additionally, epigenetic modification of modifiers of the epigenome seems to be important in haematopoietic differentiation. Our results directly demonstrate that modulation of DNA methylation occurs during lineage-specific differentiation and defines a comprehensive map of the methylation and transcriptional changes that accompany myeloid versus lymphoid fate decisions.

Subfields: Molecular Biology, Pulmonary and Respiratory Medicine

View Paper: https://www.semanticscholar.org/paper/9854897a81c1c3b4942ec6a21f1aacd0fde6152d

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Molecular Biology

Citations in the corpus

A unique regulatory phase of DNA methylation in the early mammalian embryo (2012, background): “Generally, only a small fraction of CpGs switch their methylation status as part of an orchestrated regulatory event 4–7 .”
Hematopoiesis: a human perspective. (2012, background): “Such high-resolution maps that accompany cellular transitions have been generated for mouse hematopoiesis, and are being continuously refined (Ji et al., 2010).”
Analysing and interpreting DNA methylation data (2012, background): “Second, different cell types in the same tissue or organ tend to exhibit highly characteristic DNA methylation pro‑ files 79,129 , which can lead to spurious DMRs if the cell composition is different between cases and controls.”
Reversing DNA Methylation: Mechanisms, Genomics, and Biological Functions (2014, positive): “Maintaining proper gene expression and cellular identity requires precise control of the DNA methylation pattern (Ji et al., 2010; Ziller et al., 2013).”
Reference-free cell mixture adjustments in analysis of DNA methylation data (2014, background): “However, these adjustments require the existence of reference datasets, which may be laborious or expensive to collect.”
DNA methylation arrays as surrogate measures of cell mixture distribution (2012, background): “One such epigenetic mark is DNA methylation, which is tightly associated with alterations in the nucleosome DNA scaffold (and hence chromatin) that is responsible for coordination of gene expression in individual cells [1-3].”
The role of mutations in epigenetic regulators in myeloid malignancies (2012, background): “Consistent with the coordinated gene expression changes observed during hematopoiesis, researchers have observed regular DNA methylation patterns during lineage specification and differentiation (14).”
Differential DNA Methylation in Purified Human Blood Cells: Implications for Cell Lineage and Studies on Disease Susceptibility (2012, background): “Therefore, every differentiated cell type has CpG sites that are specifically methylated or unmethylated for that specific lineage but not for others [2,9].”
Epigenetic modifications and human disease (2010, background): “Moreover, 70% of the differentially methylated regions in reprogramming are associated with CpG island shore”
Dynamic DNA methylation across diverse human cell lines and tissues (2013, background): “stable differentiation (Lei et al. 1996; Okano et al. 1999; Jackson et al. 2004; Blelloch et al. 2006; Ji et al. 2010; Kim et al. 2010), and disease, including cancer where vast changes in DNA methylation patterns occur (Laird and Jaenisch 1994; Ushijima 2005; Sharma”